Graphy Inc. has completed the final conformity assessment review under the European Union’s Medical Device Regulation for five dental 3D printing materials and is now awaiting issuance of the CE‑MDR certificates, the company said in a release. The five evaluated products include three from the TeraHarz Clear series (TC‑85DAC, TA‑28, TR‑07) and two from the TeraHarz series (TC‑80DC, BR‑23). Graphy framed the milestone as a step toward expanding local European manufacturing and distribution partnerships and strengthening its recurring materials supply, including feedstock for its printed shape‑memory aligners. The company noted prior regulatory clearances already in place, including U.S. FDA 510(k) clearance and registration with Brazil’s ANVISA, and said European certification would be used to translate its materials technology into “tangible orders and revenue.” (Source: Graphy statement in the original source). Link: https://orthodonticproductsonline.com/practice-products/practice-equipment/3d-printers/graphy-eu-medical-device-review-3d-printing-materials/
What was reported: Graphy completed the EU MDR conformity review for five named materials and is awaiting certificate issuance. The company positioned the certificate as enabling expanded local manufacturing/distribution partnerships in Europe and cited existing regulatory clearances in the U.S. and Brazil. A company release quoted chairman Un seob Sim describing the review as “significant.”
What this means for private practice: If Graphy receives CE‑MDR certificates and follows through on localized manufacturing partnerships, practices in Europe could see a new or strengthened local source of Graphy’s materials used for direct‑printed aligners and other laboratory products. For independent practices this implies potential access to regionally stocked materials and possibly shorter lead times compared with long cross‑border supply chains — provided local partners adopt Graphy’s materials. Practices should confirm any material is CE‑marked for the intended clinical use before purchasing and verify product labeling and instructions once Graphy’s certificates are issued. The company release and strategy were the only sources for these claims; monitor the certificate issuance before making procurement changes.